Judge Won't Revive FCA Medicaid Case Against Allergan, Novo

Law360, New York (November 20, 2012, 1:36 PM EST) -- A Pennsylvania federal judge Friday refused to revive False Claims Act allegations accusing Allergan Inc., Novo Nordisk Inc. and other pharmaceutical companies of defrauding Medicaid by underreporting their average manufacturer prices, saying a request for altered judgment was filed too late.

U.S. District Judge Eduardo C. Robreno concluded the altered judgment request was filed improperly more than 14 days after a July ruling largely wiped out the case of relator and pharmacist Ronald J. Streck, who has accused drug firms of concealing price increases that would have...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.